Titre : Systèmes de transport d'acides aminés neutres

Systèmes de transport d'acides aminés neutres : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multicenter Studies as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Systèmes de transport d'acides aminés neutres : Questions médicales les plus fréquentes", "headline": "Systèmes de transport d'acides aminés neutres : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Systèmes de transport d'acides aminés neutres : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-27", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Systèmes de transport d'acides aminés neutres" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Systèmes de transport d'acides aminés", "url": "https://questionsmedicales.fr/mesh/D026905", "about": { "@type": "MedicalCondition", "name": "Systèmes de transport d'acides aminés", "code": { "@type": "MedicalCode", "code": "D026905", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.200" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Système A de transport d'acides aminés", "alternateName": "Amino Acid Transport System A", "url": "https://questionsmedicales.fr/mesh/D026924", "about": { "@type": "MedicalCondition", "name": "Système A de transport d'acides aminés", "code": { "@type": "MedicalCode", "code": "D026924", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.200.500.100" } } }, { "@type": "MedicalWebPage", "name": "Système ASC de transport d'acides aminés", "alternateName": "Amino Acid Transport System ASC", "url": "https://questionsmedicales.fr/mesh/D026962", "about": { "@type": "MedicalCondition", "name": "Système ASC de transport d'acides aminés", "code": { "@type": "MedicalCode", "code": "D026962", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.200.500.200" } } }, { "@type": "MedicalWebPage", "name": "Système L de transport d'acides aminés", "alternateName": "Amino Acid Transport System L", "url": "https://questionsmedicales.fr/mesh/D027062", "about": { "@type": "MedicalCondition", "name": "Système L de transport d'acides aminés", "code": { "@type": "MedicalCode", "code": "D027062", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.200.500.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Systèmes de transport d'acides aminés neutres", "alternateName": "Amino Acid Transport Systems, Neutral", "code": { "@type": "MedicalCode", "code": "D026921", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Stefan Bröer", "url": "https://questionsmedicales.fr/author/Stefan%20Br%C3%B6er", "affiliation": { "@type": "Organization", "name": "Research School of Biology, Australian National University, Canberra, ACT, Australia." } }, { "@type": "Person", "name": "Kiran Javed", "url": "https://questionsmedicales.fr/author/Kiran%20Javed", "affiliation": { "@type": "Organization", "name": "Research School of Biology, Australian National University, Canberra, ACT, Australia." } }, { "@type": "Person", "name": "Bowen Wu", "url": "https://questionsmedicales.fr/author/Bowen%20Wu", "affiliation": { "@type": "Organization", "name": "Institute of Rice Industry Technology Research, Key Laboratory of Functional Agriculture of Guizhou Provincial, Department of Education, Key Laboratory of Molecular Breeding for Grain and oil Crops in Guizhou Province, College of Agricultural Sciences, Guizhou University, Guiyang, 550025, China." } }, { "@type": "Person", "name": "Zhongming Fang", "url": "https://questionsmedicales.fr/author/Zhongming%20Fang", "affiliation": { "@type": "Organization", "name": "Institute of Rice Industry Technology Research, Key Laboratory of Functional Agriculture of Guizhou Provincial, Department of Education, Key Laboratory of Molecular Breeding for Grain and oil Crops in Guizhou Province, College of Agricultural Sciences, Guizhou University, Guiyang, 550025, China. zmfang@gzu.edu.cn." } }, { "@type": "Person", "name": "Cesare Indiveri", "url": "https://questionsmedicales.fr/author/Cesare%20Indiveri", "affiliation": { "@type": "Organization", "name": "Department of DiBEST (Biologia, Ecologia, Scienze Della Terra) Unit of Biochemistry and Molecular Biotechnology, University of Calabria, Via Bucci 4C, 87036, Arcavacata Di Rende, CS, Italy. cesare.indiveri@unical.it." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Efficacy and safety of pentoxifylline for chronic venous leg ulcers: study protocol for a multicenter randomized controlled trial in China (ESPECT study).", "datePublished": "2023-08-02", "url": "https://questionsmedicales.fr/article/37533132", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-023-07547-y" } }, { "@type": "ScholarlyArticle", "name": "Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study.", "datePublished": "2022-11-04", "url": "https://questionsmedicales.fr/article/36333718", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12920-022-01343-4" } }, { "@type": "ScholarlyArticle", "name": "Conducting Multicenter Residency Research.", "datePublished": "2022-07-18", "url": "https://questionsmedicales.fr/article/35848055", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/08971900221116191" } }, { "@type": "ScholarlyArticle", "name": "Effect of statin use on head and neck cancer prognosis in a multicenter study using a Common Data Model.", "datePublished": "2023-11-13", "url": "https://questionsmedicales.fr/article/37957229", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-45654-7" } }, { "@type": "ScholarlyArticle", "name": "Association between psychological vulnerability and glaucoma progression: Protocol for a multicenter prospective cohort study in South Korea.", "datePublished": "2023-10-10", "url": "https://questionsmedicales.fr/article/37816064", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0292599" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Protéines de transport membranaire", "item": "https://questionsmedicales.fr/mesh/D026901" }, { "@type": "ListItem", "position": 6, "name": "Systèmes de transport d'acides aminés", "item": "https://questionsmedicales.fr/mesh/D026905" }, { "@type": "ListItem", "position": 7, "name": "Systèmes de transport d'acides aminés neutres", "item": "https://questionsmedicales.fr/mesh/D026921" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Systèmes de transport d'acides aminés neutres - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Systèmes de transport d'acides aminés neutres", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Systèmes de transport d'acides aminés neutres", "description": "Comment diagnostiquer un trouble de transport d'acides aminés ?\nQuels examens sont utilisés pour évaluer le transport d'acides aminés ?\nLes symptômes peuvent-ils indiquer un trouble de transport ?\nQuel rôle joue l'historique médical dans le diagnostic ?\nLes tests de dépistage néonatal incluent-ils ces troubles ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Systèmes de transport d'acides aminés neutres", "description": "Quels sont les symptômes d'un trouble de transport d'acides aminés ?\nLes troubles digestifs sont-ils liés à ces systèmes ?\nPeut-on observer des anomalies neurologiques ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des signes cutanés associés ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Systèmes de transport d'acides aminés neutres", "description": "Peut-on prévenir les troubles de transport d'acides aminés ?\nL'alimentation joue-t-elle un rôle préventif ?\nLes conseils génétiques sont-ils utiles ?\nLe suivi médical régulier est-il important ?\nLes vaccinations ont-elles un impact ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Systèmes de transport d'acides aminés neutres", "description": "Quels traitements sont disponibles pour ces troubles ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils aider ?\nComment un régime alimentaire peut-il aider ?\nY a-t-il des traitements expérimentaux ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Systèmes de transport d'acides aminés neutres", "description": "Quelles complications peuvent survenir ?\nLes troubles psychologiques sont-ils possibles ?\nY a-t-il des risques de maladies métaboliques ?\nLes complications peuvent-elles affecter la qualité de vie ?\nDes problèmes de croissance peuvent-ils survenir ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Systèmes de transport d'acides aminés neutres", "description": "Quels sont les facteurs de risque génétiques ?\nL'alimentation peut-elle influencer le risque ?\nLes infections peuvent-elles aggraver la situation ?\nL'âge parental joue-t-il un rôle ?\nY a-t-il des facteurs environnementaux à considérer ?", "url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un trouble de transport d'acides aminés ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses sanguines peuvent être effectués pour évaluer le transport." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer le transport d'acides aminés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de concentration d'acides aminés dans le sang et l'urine sont courants." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils indiquer un trouble de transport ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la fatigue ou des troubles de croissance peuvent alerter." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier des antécédents familiaux de troubles métaboliques." } }, { "@type": "Question", "name": "Les tests de dépistage néonatal incluent-ils ces troubles ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains programmes de dépistage néonatal incluent des tests pour ces troubles." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un trouble de transport d'acides aminés ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, retard de croissance et troubles neurologiques." } }, { "@type": "Question", "name": "Les troubles digestifs sont-ils liés à ces systèmes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles digestifs peuvent survenir en raison d'une malabsorption des acides aminés." } }, { "@type": "Question", "name": "Peut-on observer des anomalies neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies neurologiques peuvent se manifester en raison d'un manque d'acides aminés." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon l'âge et le type de trouble de transport." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Certaines carences peuvent entraîner des éruptions cutanées ou des problèmes dermatologiques." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles de transport d'acides aminés ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est limitée, mais un dépistage précoce peut aider à gérer les cas." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle préventif ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut aider à prévenir certaines carences en acides aminés." } }, { "@type": "Question", "name": "Les conseils génétiques sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les conseils génétiques peuvent aider les familles à comprendre les risques héréditaires." } }, { "@type": "Question", "name": "Le suivi médical régulier est-il important ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical régulier peut aider à détecter les problèmes tôt." } }, { "@type": "Question", "name": "Les vaccinations ont-elles un impact ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations n'ont pas d'impact direct sur les troubles de transport d'acides aminés." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour ces troubles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des régimes alimentaires spécifiques et des suppléments d'acides aminés." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en cours d'étude pour certains troubles de transport d'acides aminés." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent améliorer l'absorption ou réduire les symptômes associés." } }, { "@type": "Question", "name": "Comment un régime alimentaire peut-il aider ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un régime adapté peut compenser les carences en acides aminés et améliorer la santé." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements expérimentaux sont en cours pour certains troubles rares." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des retards de développement et des troubles neurologiques." } }, { "@type": "Question", "name": "Les troubles psychologiques sont-ils possibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles psychologiques peuvent survenir en raison de carences nutritionnelles." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies métaboliques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies métaboliques peuvent se développer si les troubles ne sont pas traités." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients." } }, { "@type": "Question", "name": "Des problèmes de croissance peuvent-ils survenir ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes de croissance sont fréquents chez les enfants atteints de ces troubles." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque génétiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de troubles métaboliques augmentent le risque." } }, { "@type": "Question", "name": "L'alimentation peut-elle influencer le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en acides aminés peut augmenter le risque de carences." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver la situation ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent exacerber les symptômes des troubles de transport." } }, { "@type": "Question", "name": "L'âge parental joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé des parents peut être un facteur de risque pour certaines anomalies." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à considérer ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains facteurs environnementaux peuvent influencer le développement de ces troubles." } } ] } ] }

Sources (10000 au total)

Efficacy and safety of pentoxifylline for chronic venous leg ulcers: study protocol for a multicenter randomized controlled trial in China (ESPECT study).

Venous leg ulcers (VLUs) are the most severe manifestation of chronic venous disease, with long healing time and a high recurrence rate. It imposes a heavy burden on patients, their families, and the ... This is a randomized, double-blinded, double-dummy, multi-center, placebo-controlled clinical trial. A total of 240 patients will be randomized to receive pentoxifylline (400 mg, twice daily) or place... This study would evaluate the efficacy and safety of pentoxifylline for VLUs in the Chinese population. If confirmed, it wound offer another effective and safe therapeutic option for treatment of VLUs... The trial was registered at the Chinese Clinical Trial Registry (No. ChiCTR-2100053053). Registered on 10 November, 2021, https://www.chictr.org.cn/showproj.aspx?proj=137010....

Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study.

Glioblastoma (GBM), the most common glial primary brain tumour, is without exception lethal. Every year approximately 600 patients are diagnosed with this heterogeneous disease in The Netherlands. Des... The GLOW study is a prospective diagnostic cohort study executed through collaboration of the Hartwig Medical Foundation (Hartwig, a non-profit organisation) and twelve Dutch centers that perform neur... The GLOW study aims to provide the scientific evidence for changing the SOC diagnostics for patients with a recurrent glioblastoma by investigating complete genome diagnostics to maximize treatment op... ClinicalTrials.gov Identifier: NCT05186064....

Conducting Multicenter Residency Research.

Conducting well designed pharmacy resident research projects has inherent challenges including inadequate sample size, a lack of time, decreased generalizability, and inadequate research support. A wa... This article includes a general approach to conducting multicenter research from experienced individuals based upon their successes and failures. A timeline-based format is presented to lay the ground... Conducting multicenter residency research projects requires a team-based approach and advanced planning. This approach has the potential to improve pharmacy resident project quality....

Association between psychological vulnerability and glaucoma progression: Protocol for a multicenter prospective cohort study in South Korea.

Mental health is a significant concern for patients diagnosed with glaucoma, as visual impairment can have a profound impact on psychological well-being. Conversely, psychological vulnerability in gla... This study is to be a prospective multicenter study conducted at four tertiary medical centers. Patients recently diagnosed with glaucoma and not yet treated will be enrolled. Anxiety, depression, and...

A multicenter, phase Ib/II, open-label study of tivozanib with durvalumab in advanced hepatocellular carcinoma (DEDUCTIVE).

Durvalumab, a PD-L1 inhibitor, is part of an immunotherapeutic drug class shown to have prolonged survival benefit in patients with advanced stage hepatocellular carcinoma (HCC). Tivozanib is a potent...

Sexual well-being among older adults in China (SWELL): protocol for a multicenter cross-sectional study.

Existing studies on sexual health generally focus on younger populations, while the sexual well-being of older adults has received insufficient attention. This protocol describes the design of a study... We present the protocol for a multicentre observational study to investigate sexual well-being among Chinese older adults (SWELL). Eligible participants are men and women aged 50 years and older from ... This study was approved by the Human Research Ethics Committee of the School of Public Health (Shenzhen), Sun Yat-sen University (approval number SYSU-PHS[2019]006). Verbal informed consent will be ob...

Effects of the "ICU Support" team meeting concept on patient-centered and staff-centered outcomes: study protocol for a randomized controlled multicenter study.

Providing optimal care for critically ill patients is an extremely important but also highly demanding task, both emotionally and physically. The "ICU Support" team meeting concept aims to support int... ICU Support will be implemented at nine university hospitals located in Germany, following a two-arm randomized parallel group design with an intervention and a control condition and three data collec... The need for healthy and well-trained ICU staff is omnipresent; thus, structured and evidence-based interventions aimed at supporting ICU teams and facilitating patient safety are required. This multi... German Clinical Trials Register DRKS00028642 . Registered on 4 April 2022....

An analysis of the experiences of bereaved relatives and health care providers following palliative sedation: a study protocol for a qualitative international multicenter case study.

Patients at the end-of-life may experience refractory symptoms of which pain, delirium, vomiting and dyspnea are the most frequent. Palliative sedation can be considered a last resort option to allevi... This study protocol is part of the larger HORIZON 2020 Palliative Sedation project. Organisational case study methodology will be used to guide the study design. In total, 50 cases will be conducted i... The study aims to have a better understanding of the experiences of relatives and professional caregivers regarding palliative sedation and this within different settings and countries. Some limitatio...

Benefit of extending the protocol for high resolution manometry according to the version 4.0 of the Chicago criteria. A multicenter study.

The last version of the Chicago Criteria for high resolution esophageal manometry proposes an expanded protocol including complementary maneuvers to improve the diagnostic yield of the exploration. Ou... All manometry recordings performed in 4 reference centers during the first 10 months after the implementation of the new protocol were retrospectively reviewed. The time spent to complete the protocol... From a total of 756 HRM performed, 606 studies could be properly analyzed. The duration of the studies was 18.3 ± 4.3 min. From these, 11.3 ± 3.4 min were spent to complete the CCv3.0 protocol, and 7.... Prolongation of the time spent to complete the CCv4.0 protocol leads to a change in the diagnosis of 12% of patients. Clinically relevant changes are mainly related to the evaluation of EGJOO....